Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
13,944,728
-
Shares change
-
-8,761
-
Total reported value, excl. options
-
$50,758,465
-
Value change
-
-$946,527
-
Put/Call ratio
-
11%
-
Number of buys
-
23
-
Number of sells
-
-25
-
Price
-
$3.64
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2023
69 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q3 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,944,728 shares
of 28,736,767 outstanding shares and own 48.53% of the company stock.
Largest 10 shareholders include Corvex Management LP (3,307,523 shares), Casdin Capital, LLC (3,095,511 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,253,895 shares), ORACLE INVESTMENT MANAGEMENT INC (994,580 shares), Blackstone Inc. (835,062 shares), Soleus Capital Management, L.P. (781,396 shares), MARSHALL WACE, LLP (699,528 shares), VANGUARD GROUP INC (678,937 shares), GAGNON SECURITIES LLC (376,083 shares), and HighTower Advisors, LLC (237,948 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.